Treatment of pain associated with deep endometriosis: alternatives and evidence

Simone Ferrero; Franco Alessandri; Annalisa Racca; Umberto Leone Roberti Maggiore

doi:10.1016/j.fertnstert.2015.08.031

Treatment of pain associated with deep endometriosis: alternatives and evidence

Simone Ferrero, Franco Alessandri, Annalisa Racca, Umberto Leone Roberti Maggiore

Fertility and sterility · 2015 · vol. 104(4) , pp. 771–792 · doi:10.1016/j.fertnstert.2015.08.031 · PMID:26363387 · W2153676064

review OA: closed CC0 ⤵ 91 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This paper reviews treatment options and evidence for pain management in patients with deep endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Endometriosis Pain Management Pelvic Pain Pelvic Pain Analgesics Analgesics Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Hormone Antagonists Hormone Antagonists Humans Pain Management Pelvic Pain Progestins Progestins Severity of Illness Index

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (50)

Source provenance

europepmc: last seen: 2026-06-22T06:15:23.361955+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:17:39.907309+00:00

License: CC0 · commercial use OK

[1] A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system via openalex

[2] Accuracy of magnetic resonance imaging for diagnosis and preoperative assessment of deeply infiltrating endometriosis via openalex

[3] Accuracy of transvaginal sonography and contrast‐enhanced magnetic resonance‐colonography for the presurgical staging of deep infiltrating endometriosis via openalex

[4] Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta‐analysis via openalex

[5] A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group. via openalex

[6] A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis via openalex

[7] A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex

[8] Anatomical distribution of pelvic deep infiltrating endometriosis and its relationship with pain symptoms. via openalex

[9] A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg via openalex

[10] Angiogenesis lymphangiogenesis and neurogenesis in endometriosis via openalex

[11] Anterior rectal wall excision for endometriosis using the circular stapler via openalex

[12] Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in vitro via openalex

[13] A pilot study to evaluate the clinical relevance of endometriosis-associated nerve fibers in peritoneal endometriotic lesions via openalex

[14] Are digestive symptoms in women presenting with pelvic endometriosis specific to lesion localizations? A preliminary prospective study via openalex

[15] Aromatase and endometriosis: estrogens play a role via openalex

[16] Associated ovarian endometrioma is a marker for greater severity of deeply infiltrating endometriosis via openalex

[17] Association rate between deep peritoneal endometriosis and other forms of the disease: pathogenetic implications via openalex

[18] Bowel dysfunction before and after surgery for endometriosis via openalex

[19] Bowel endometriosis: Colorectal surgeon’s perspective in a multidisciplinary surgical team via openalex

[20] Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study via openalex

[21] Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma via openalex

[22] Changes in quality of life after hormonal treatment of endometriosis via openalex

[23] Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies via openalex

[24] Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex

[25] Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications via openalex

[26] Chronic Pelvic Pain in Endometriosis: An Overview via openalex

[27] Clinical Outcome After Radical Excision of Moderate—Severe Endometriosis With or Without Bowel Resection and Reanastomosis via openalex

[28] Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan. via openalex

[29] Combined Oral Contraceptive Therapy in Women with Posterior Deep Infiltrating Endometriosis via openalex

[30] Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex

[31] Comparison of Cyproterone Acetate and Danazol in the Treatment of Pelvic Pain Associated With Endometriosis via openalex

[32] Complications, pregnancy and recurrence in a prospective series of 500 patients operated on by the shaving technique for deep rectovaginal endometriotic nodules via openalex

[33] Continuous low‐dose oral contraceptive in the treatment of colorectal endometriosis evaluated by rectal endoscopic ultrasonography via openalex

[34] Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex

[35] Continuous use of oral contraceptives: an overview of effects and side‐effects via openalex

[36] Correlation between endometriosis and pelvic pain via openalex

[37] Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis via openalex

[38] Danazol in the treatment of vesical endometriosis. via openalex

[39] Deep endometriosis: definition, diagnosis, and treatment via openalex

[40] Deep endometriosis, including intestinal involvement – the interdisciplinary approach via openalex

[41] Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management via openalex

[42] Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease via openalex

[43] Delayed functional outcomes associated with surgical management of deep rectovaginal endometriosis with rectal involvement: giving patients an informed choice via openalex

[44] Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex

[45] Diagnosis, management, and long-term outcomes of rectovaginal endometriosis via openalex

[46] Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis via openalex

[47] Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells via openalex

[48] Dienogest for the treatment of deep endometriosis: Case report and literature review via openalex

[49] Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex

[50] Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment via openalex

[51] Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex

[52] Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex

[53] Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis via openalex

[54] Differences in characteristics among 1,000 women with endometriosis based on extent of disease via openalex

[55] Dioxin and Endometrial Progesterone Resistance via openalex

[56] Dioxin may promote inflammation-related development of endometriosis via openalex

[57] Discoid or segmental rectosigmoid resection for deep infiltrating endometriosis: a case-control study via openalex

[58] Does laparoscopic management of deep infiltrating endometriosis improve quality of life? A prospective study via openalex

[59] Double Circular Stapler Technique for Bowel Resection in Rectosigmoid Endometriosis via openalex

[60] Dyspareunia and quality of sex life after surgical excision of endometriosis: a systematic review via openalex

[61] Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies via openalex

[62] Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis via openalex

[63] Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue via openalex

[64] Effects of Triptorelin Versus Placebo on the Symptoms of Endometriosis via openalex

[65] Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis via openalex

[66] Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis via openalex

[67] Emerging therapy for endometriosis via openalex

[68] Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications via openalex

[69] Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations via openalex

[70] Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis via openalex

[71] Endometriosis-induced vaginal hyperalgesia in the rat: Effect of estropause, ovariectomy, and estradiol replacement via openalex

[72] Endometriosis Lesions That Compromise the Rectum Deeper Than the Inner Muscularis Layer Have More Than 40% of the Circumference of the Rectum Affected by the Disease via openalex

[73] Estrogen metabolizing enzymes in endometrium and endometriosis via openalex

[74] Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis via openalex

[75] Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial via openalex

[76] Follow-up of dysfunctional bladder and rectum after surgery of a deep infiltrating rectovaginal endometriosis via openalex

[77] Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas via openalex

[78] Gonadotropin-Releasing Hormone Agonist (GnRH-a) Therapy Alters Activity of Plasminogen Activators, Matrix Metalloproteinases, and Their Inhibitors in Rat Models for Adhesion Formation and Endometriosis: Potential GnRH-a–Regulated Mechanisms Reducing Adhesion Formation via openalex

[79] Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum via openalex

[80] High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis via openalex

[81] Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis via openalex

[82] Hormonal Treatment for Severe Hydronephrosis Caused by Bladder Endometriosis via openalex

[83] How complete is full thickness disc resection of bowel endometriotic lesions? A prospective surgical and histological study via openalex

[84] Hyperinnervation in Intestinal Deep Infiltrating Endometriosis via openalex

[85] Improvement of digestive complaints in women with severe colorectal endometriosis benefiting from continuous amenorrhoea triggered by triptorelin. A prospective pilot study via openalex

[86] Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis via openalex

[87] Innervation of ectopic endometrium in a rat model of endometriosis via openalex

[88] Intestinal endometriosis without evident pelvic foci treated with gonadotropin-releasing hormone agonist via openalex

[89] Laparoscopic nerve-sparing complete excision of deep endometriosis: is it feasible? via openalex

[90] Laparoscopic Resection of Deep Pelvic Endometriosis with Rectosigmoid Involvement via openalex

[91] Laparoscopic surgery for bowel endometriosis. via openalex

[92] Laparoscopic treatment of complete obliteration of the cul-de-sac associated with endometriosis: long-term follow-up of en bloc resection via openalex

[93] Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis via openalex

[94] Letrozole and desogestrel‐only contraceptive pill for the treatment of stage IV endometriosis via openalex

[95] Letrozole and norethisterone acetate in colorectal endometriosis via openalex

[96] Letrozole and norethisterone acetate in rectovaginal endometriosis via openalex

[97] Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial via openalex

[98] Leuprolide acetate for the treatment of endometriosis. via openalex

[99] Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex

[100] Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex